Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ciabatti

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
The Journal of Antibiotics|August 1, 1995
New semisynthetic glycopeptides MDL 63,246 and MDL 63,042, and other amide derivatives of antibiotic A-40,926 active against highly glycopeptide-resistant VanA enterococciA Malabarba, R Ciabatti, R Scotti, et al.
Journal of Medicinal Chemistry|October 1, 1986
Structure-activity studies of 16-methoxy-16-methyl prostaglandinsU Guzzi, R Ciabatti, G Padova, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 1, 1985
Metabolic pathways of the anti-hypertensive agent, N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride. II: Studies in the dogA Assandri, A Perazzi, E Bellasio, et al.
Journal of Industrial Microbiology|November 1, 1992
Isolation, structure determination and biological activity of A-16686 factors A' 1, A' 2 and A' 3 glycolipodepsipeptide antibioticsL Gastaldo, R Ciabatti, F Assi, et al.
Bioorganicheskaia Khimiia|May 1, 1997
[Non-natural aglycones of glycopeptide antibiotics of the vancomycin group. Synthesis and antibacterial activity]A Iu Pavlov, E N Olsuf'eva, O V Miroshnikova, et al.
The Journal of Antibiotics|November 1, 1996
A modification of the N-terminal amino acid in the eremomycin aglyconeO V Miroshnikova, T F Berdnikova, E N Olsufyeva, et al.
The Journal of Antibiotics|January 1, 1997
Substitution of amino acids 1 and 3 in teicoplanin aglycon: synthesis and antibacterial activity of three first non-natural dalbaheptidesA Malabarba, R Ciabatti, E Gerli, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The Journal of Antibiotics|August 1, 1995
New semisynthetic glycopeptides MDL 63,246 and MDL 63,042, and other amide derivatives of antibiotic A-40,926 active against highly glycopeptide-resistant VanA enterococciA Malabarba, R Ciabatti, R Scotti, et al.
Journal of Medicinal Chemistry|October 1, 1986
Structure-activity studies of 16-methoxy-16-methyl prostaglandinsU Guzzi, R Ciabatti, G Padova, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 1, 1985
Metabolic pathways of the anti-hypertensive agent, N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride. II: Studies in the dogA Assandri, A Perazzi, E Bellasio, et al.
Journal of Industrial Microbiology|November 1, 1992
Isolation, structure determination and biological activity of A-16686 factors A' 1, A' 2 and A' 3 glycolipodepsipeptide antibioticsL Gastaldo, R Ciabatti, F Assi, et al.
Bioorganicheskaia Khimiia|May 1, 1997
[Non-natural aglycones of glycopeptide antibiotics of the vancomycin group. Synthesis and antibacterial activity]A Iu Pavlov, E N Olsuf'eva, O V Miroshnikova, et al.
The Journal of Antibiotics|November 1, 1996
A modification of the N-terminal amino acid in the eremomycin aglyconeO V Miroshnikova, T F Berdnikova, E N Olsufyeva, et al.
The Journal of Antibiotics|January 1, 1997
Substitution of amino acids 1 and 3 in teicoplanin aglycon: synthesis and antibacterial activity of three first non-natural dalbaheptidesA Malabarba, R Ciabatti, E Gerli, et al.
Pageof 4